Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I. J. Jacobs

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|November 29, 2005
Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?A G Rockall, S Ghosh, F Alexander-Sefre, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based seriesN D Macdonald, H B Salvesen, A Ryan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningU Menon, A Talaat, A N Rosenthal, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
British Journal of Cancer|July 17, 1999
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevationU Menon, A Talaat, A R Jeyarajah, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|November 29, 2005
Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?A G Rockall, S Ghosh, F Alexander-Sefre, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based seriesN D Macdonald, H B Salvesen, A Ryan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningU Menon, A Talaat, A N Rosenthal, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
British Journal of Cancer|July 17, 1999
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevationU Menon, A Talaat, A R Jeyarajah, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
Pageof 7